A randomised placebo-controlled study of Tamsulosin, Voltarol and the combination in types IIIa and IIIb prostatitis using the newly developed and validated National Institutes of Health (NIH) symptom score

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46815629

Enrollment

Registered

2003-09-12

Start date

2000-05-04

Completion date

Unknown

Last updated

2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases: Prostatitis Urological and Genital Diseases Prostatitis

Interventions

The study is a randomised controlled trial using four arms in the treatment of chronic pelvic pain syndrome in men: 1. Placebo only 2. Tamsulosin 3. Vo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 60 patients aged between 30 and 50

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026